- Home
- MBRX vs ONMD Comparison
MBRX vs ONMD Comparison
Compare MBRX & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- ONMD
- Stock Information
- Founded
- MBRX 2015
- ONMD 2006
- Country
- MBRX United States
- ONMD United States
- Employees
- MBRX N/A
- ONMD N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- ONMD
- Sector
- MBRX Health Care
- ONMD
- Exchange
- MBRX Nasdaq
- ONMD Nasdaq
- Market Cap
- MBRX 12.9M
- ONMD 12.8M
- IPO Year
- MBRX 2016
- ONMD N/A
- Fundamental
- Price
- MBRX $0.31
- ONMD $0.52
- Analyst Decision
- MBRX Strong Buy
- ONMD
- Analyst Count
- MBRX 3
- ONMD 0
- Target Price
- MBRX $5.33
- ONMD N/A
- AVG Volume (30 Days)
- MBRX 5.2M
- ONMD 25.2M
- Earning Date
- MBRX 08-13-2025
- ONMD 05-14-2025
- Dividend Yield
- MBRX N/A
- ONMD N/A
- EPS Growth
- MBRX N/A
- ONMD N/A
- EPS
- MBRX N/A
- ONMD N/A
- Revenue
- MBRX N/A
- ONMD $532,000.00
- Revenue This Year
- MBRX N/A
- ONMD N/A
- Revenue Next Year
- MBRX N/A
- ONMD N/A
- P/E Ratio
- MBRX N/A
- ONMD N/A
- Revenue Growth
- MBRX N/A
- ONMD N/A
- 52 Week Low
- MBRX $0.25
- ONMD $0.30
- 52 Week High
- MBRX $4.71
- ONMD $1.60
- Technical
- Relative Strength Index (RSI)
- MBRX 24.39
- ONMD 56.88
- Support Level
- MBRX $0.25
- ONMD $0.34
- Resistance Level
- MBRX $0.42
- ONMD $0.91
- Average True Range (ATR)
- MBRX 0.06
- ONMD 0.08
- MACD
- MBRX -0.03
- ONMD 0.02
- Stochastic Oscillator
- MBRX 13.07
- ONMD 35.37
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.